Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer

Cisplatin (CDDP)-based combination chemotherapy remains the mainstream treatment for advanced bladder cancer. However, its efficacy is often limited due to the development of resistance for which underlying mechanisms are poorly understood. Meanwhile, emerging evidence has indicated the involvement...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Kashiwagi, Eiji, Ide, Hiroki, Inoue, Satoshi, Kawahara, Takashi, Zheng, Yichun, Reis, Leonardo O., Baras, Alexander S., Miyamoto, Hiroshi
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226499/
https://ncbi.nlm.nih.gov/pubmed/27322140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9994
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items